- Home
- WOLF vs HQL Comparison
WOLF vs HQL Comparison
Compare WOLF & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WOLF | HQL |
|---|---|---|
| Founded | 1987 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Investment Managers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.2M | 512.1M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | WOLF | HQL |
|---|---|---|
| Price | $15.71 | $16.93 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $8.83 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 120.9K |
| Earning Date | 02-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $759,700,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.39 | N/A |
| P/E Ratio | ★ N/A | $17.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.05 | $11.34 |
| 52 Week High | $36.60 | $14.37 |
Technical Indicators
Market Signals| Indicator | WOLF | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 33.15 | 49.59 |
| Support Level | $16.93 | $16.35 |
| Resistance Level | $18.69 | $17.40 |
| Average True Range (ATR) | 1.52 | 0.33 |
| MACD | -0.31 | 0.02 |
| Stochastic Oscillator | 0.15 | 52.61 |
Price Performance
Historical ComparisonAbout WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.